Acute Respiratory Distress Syndrom
Respiratory support is still the cornerstone therapy of acute respiratory distress syndrom (ARDS) in both children and adults. Despite progress due to lung-protective strategies, failure of conventional mechanical ventilation results in unacceptably high mortality and morbidity. ARDS in adults has an incidence of 10-14 cases per 100 000 habitants per year and a mortality rate of 31%. A number of preclinical studies suggest clear benefits from total liquid ventilation (TLV) in ARDS. Hence, as an alternative respiratory support for ARDS, the liquid ventilator could be introduced in all intensive care units.